Specialty Pharmaceuticals Industry Financials, Performance and Ratios
-
Industry Score
27.1 /100
Rank 109 out of 131 Industries -
Advance/Decline
10/12
-
No. of Companies22
-
Avg. Market Cap3,534
-
Price to Earning Ratio35.54
-
Price to Earning Growth Ratio0.48
-
Price to Book Ratio8.77
-
Return on Equity34.08
-
Return on Capital Employed-
-
Return on Assets15.73
-
Dividend yield 1 year %0.00
-
Net Profit Growth Annual YoY %-681.60 %
-
Net Profit Growth Qtr YoY %-136.18 %
-
Net Profit Growth Qtr QoQ %-393.46 %
Show more
*All values are market cap weighted averages.
*All Financial parameters are in Million USD.
Specialty Pharmaceuticals Industry Market Breadth
- < -5%
- -2 to -5%
- 0 to -2%
- 0 to 2%
- 2 to 5%
- > 5%
Specialty Pharmaceuticals Peer comparison
Compare all stocks in Specialty Pharmaceuticals industry listed on stock exchanges
| Stock Name | 3M Price Chart | Market Cap | LTPLast Traded Price | Day High Low (%) | Week High Low (%) | Month High Low (%) | Qtr High Low(%) | 1 Year High low(%) | 3 Year High low(%) | 5 Year High low(%) | 10 Year High low(%) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Usana Health Sciences Inc |
|
311.9
|
16.9
|
L
 -1.9%
H
16.6
17.1
|
L
 -2.2%
H
16.6
17.8
|
L
 -15.9%
H
16.6
19.9
|
L
 -13.1%
H
16.6
22.9
|
L
 -37.8%
H
16.6
38.3
|
L
 -73.1%
H
16.6
69.6
|
L
 -83.0%
H
16.6
107.9
|
L
 -72.3%
H
16.6
138.0
|
| Argen X SE (ADR) |
|
46,325.0
|
746.4
|
L
 0.4%
H
735.5
760
|
L
 7.7%
H
690.9
760
|
L
 -1.4%
H
661.9
760
|
L
 -11.1%
H
661.9
881.9
|
L
 27.9%
H
510.1
934.6
|
L
 100.3%
H
327.7
934.6
|
L
 164.4%
H
248.2
934.6
|
L
H
17.3
934.6
|
| Biondvax Pharma Ltd (ADR) |
|
-
|
0.6
|
L
 -6.3%
H
0.6
0.6
|
L
H
0.6
0.7
|
L
 -29.4%
H
0.6
1.1
|
L
 -17.8%
H
0.6
1.1
|
L
 -79.4%
H
0.6
6.2
|
L
 -72.2%
H
0.6
6.2
|
L
 -98.5%
H
0.6
99
|
L
 -98.4%
H
0.6
620
|
| Niagen Bioscience Inc |
|
350.8
|
4.4
|
L
 -3.1%
H
4.3
4.5
|
L
 -2.0%
H
4.2
4.6
|
L
 -12.2%
H
4.2
5.8
|
L
 -29.9%
H
4.2
6.9
|
L
 -38.1%
H
4.2
14.7
|
L
 186.3%
H
1.3
14.7
|
L
 -54.8%
H
1.2
14.7
|
L
 2.1%
H
1.2
23.7
|
| Cronos Grp Inc |
|
959.0
|
2.5
|
L
 0.8%
H
2.5
2.6
|
L
 0.4%
H
2.4
2.6
|
L
 -3.8%
H
2.4
2.7
|
L
 -6.3%
H
2.4
2.8
|
L
 39.8%
H
1.6
3.4
|
L
 30.4%
H
1.6
3.4
|
L
 -73.1%
H
1.6
9.6
|
L
H
0.2
25.1
|
| Enveric Biosciences Inc |
|
3.8
|
2.0
|
L
 -5.1%
H
2.0
2.1
|
L
 9.1%
H
1.8
2.2
|
L
 -9.8%
H
1.8
2.2
|
L
 -44.7%
H
1.8
4.7
|
L
 -87.6%
H
1.8
17.8
|
L
 -99.3%
H
1.8
1256.4
|
L
 -100.0%
H
1.8
33660
|
L
 -100.0%
H
1.8
12150000
|
| ZeroStack Corp |
|
13.7
|
5.6
|
L
 -6.0%
H
5.5
6.0
|
L
 -13.7%
H
5.2
7.8
|
L
 -22.2%
H
5.2
9.7
|
L
 -18.0%
H
5.2
15.0
|
L
 -73.3%
H
5.2
47
|
L
 -97.5%
H
5.2
235.3
|
L
H
5.2
16731
|
L
H
5.2
16731
|
| IM Cannabis Corp |
|
2.0
|
0.3
|
L
 13.3%
H
0.3
0.4
|
L
 -32%
H
0.3
0.5
|
L
 -52.8%
H
0.3
1.1
|
L
 -77.2%
H
0.3
1.6
|
L
 -78.5%
H
0.3
7.1
|
L
 -92.1%
H
0.3
8.6
|
L
 -99.9%
H
0.3
484.2
|
L
H
0.3
697.8
|
| Lifevantage Corp |
|
54.4
|
4.3
|
L
 1.2%
H
4.1
4.3
|
L
 -0.9%
H
4.1
4.5
|
L
 -6.0%
H
4.1
5.4
|
L
 -29.5%
H
3.9
6.8
|
L
 -73.5%
H
3.9
15.5
|
L
 18.4%
H
3.0
27.4
|
L
 -55.0%
H
3.0
27.4
|
L
 -53.4%
H
2.9
27.4
|
| Mannatech Inc |
|
11.0
|
5.8
|
L
 -8.4%
H
5.8
5.9
|
L
 -16.7%
H
5.8
6.8
|
L
 -15.1%
H
5.8
7.0
|
L
 -30.7%
H
5.8
9.5
|
L
 -31.2%
H
5.8
12.5
|
L
 -66.4%
H
5.8
17.9
|
L
 -70.5%
H
5.8
49.1
|
L
 -73.7%
H
5.8
49.1
|
| Natural Alternatives Intl Inc |
|
16.6
|
2.7
|
L
H
2.6
2.7
|
L
 -1.8%
H
2.6
2.9
|
L
 -1.1%
H
2.5
3.3
|
L
 -25.4%
H
2.3
5.0
|
L
 -22.3%
H
2.3
5.0
|
L
 -70.9%
H
2.3
9.4
|
L
 -83.4%
H
2.3
19.9
|
L
 -80.3%
H
2.3
19.9
|
| Nature`s Sunshine Products Inc |
|
424.6
|
24.3
|
L
 -0.9%
H
23.8
24.4
|
L
 2.6%
H
23.3
24.8
|
L
 -12.8%
H
22.7
27.9
|
L
 15.6%
H
20.9
28.1
|
L
 95.7%
H
11.0
28.1
|
L
 137.5%
H
9.9
28.1
|
L
 24.4%
H
7.9
28.1
|
L
 157.2%
H
5.5
28.1
|
| Paranovus Entertainment Tech Ltd (Class A) |
|
1.7
|
1.8
|
L
 -11.5%
H
1.8
2
|
L
 -38.9%
H
1.8
3.1
|
L
 -88.2%
H
1.8
28.4
|
L
 -92.4%
H
1.8
36.5
|
L
 -99.9%
H
1.8
1680
|
L
 -100.0%
H
1.8
6408
|
L
 -100.0%
H
1.8
50404.8
|
L
H
1.8
146400
|
| PharmaCyte Biotech Inc |
|
7.4
|
0.7
|
L
H
0.7
0.8
|
L
 -11.5%
H
0.7
0.8
|
L
 -1.4%
H
0.6
0.8
|
L
 -6.8%
H
0.6
1.1
|
L
 -46.9%
H
0.6
1.5
|
L
 -76.3%
H
0.6
3.2
|
L
 -97.7%
H
0.6
31.1
|
L
 -99.3%
H
0.6
253.4
|
| AIxCrypto Holdings Inc |
|
6.6
|
1.3
|
L
 3.2%
H
1.2
1.3
|
L
 8.5%
H
1.1
1.3
|
L
 12.3%
H
1.0
1.5
|
L
 -46.7%
H
0.9
2.9
|
L
 -62.5%
H
0.9
8.8
|
L
 -97.2%
H
0.1
63
|
L
 -99.9%
H
0.1
1560
|
L
 -100.0%
H
0.1
468750
|
| Revolution Medicines Inc |
|
19,642.9
|
99.1
|
L
 0.5%
H
96.5
101
|
L
 6.3%
H
91.5
101
|
L
 -2.5%
H
91.5
102.4
|
L
 25.4%
H
76.3
124.5
|
L
 186.5%
H
29.2
124.5
|
L
 357.6%
H
15.5
124.5
|
L
 111.6%
H
14.1
124.5
|
L
H
14.1
124.5
|
| Upexi Inc |
|
68.0
|
1.0
|
L
 -1.0%
H
0.9
1.0
|
L
 -8.4%
H
0.9
1.1
|
L
 11.4%
H
0.8
1.3
|
L
 -48.7%
H
0.5
2.5
|
L
 -55.5%
H
0.5
22.5
|
L
 -98.8%
H
0.5
91
|
L
H
0.5
187.4
|
L
H
0.5
187.4
|
| Scinai Immunotherapeutics Ltd (ADR) |
|
2.1
|
0.6
|
L
 -6.3%
H
0.6
0.6
|
L
H
0.6
0.7
|
L
 -29.4%
H
0.6
1.1
|
L
 -17.8%
H
0.6
1.1
|
L
 -79.0%
H
0.6
6.2
|
L
 -97.2%
H
0.6
46.9
|
L
 -99.8%
H
0.6
419
|
L
 -99.8%
H
0.6
6200
|
| FitLife Brands Inc |
|
99.6
|
10.6
|
L
 -12.3%
H
10.1
12.1
|
L
 -23.3%
H
10.1
14.5
|
L
 -29.6%
H
10.1
15.3
|
L
 -32.7%
H
10.1
16.9
|
L
 -13.7%
H
9.8
21.0
|
L
 -35.9%
H
9.8
35.5
|
L
 -35.9%
H
9.8
35.5
|
L
 -35.9%
H
9.8
35.5
|
| Abivax (ADR) |
|
9,371.0
|
118.4
|
L
 3.0%
H
112
119.8
|
L
 8.1%
H
100.2
119.8
|
L
 4.7%
H
100.2
127
|
L
 -11.5%
H
100.2
133.4
|
L
 1856.5%
H
4.8
148.8
|
L
H
4.8
148.8
|
L
H
4.8
148.8
|
L
H
4.8
148.8
|
| Synergy CHC Corp |
|
9.0
|
0.8
|
L
 -21.6%
H
0.8
1.0
|
L
 -32.2%
H
0.7
1.3
|
L
 -42.5%
H
0.7
1.5
|
L
 -57.5%
H
0.7
2.2
|
L
 -68.4%
H
0.7
4.1
|
L
H
0.7
4.6
|
L
H
0.7
4.6
|
L
H
0.7
4.6
|
| iBio Inc |
|
68.4
|
2.0
|
L
 1.5%
H
1.9
2.0
|
L
 13.8%
H
1.7
2.0
|
L
 -26.4%
H
1.4
2.9
|
L
 -2.0%
H
1.4
3.1
|
L
 147.5%
H
0.6
3.8
|
L
 147.5%
H
0.6
3.8
|
L
 147.5%
H
0.6
3.8
|
L
 147.5%
H
0.6
3.8
|